Medical economics

SGLT2i, GLP-1 RA prescribing lower for minority patients

Pharmacy dispensing patterns for sodium-glucose cotransporter 2 inhibitor (SGLT2i) and glucagon-like peptide 1 receptor agonist (GLP1-RA) medications show lower prescribing for minority patients; and the rate of SGLT2i prescriptions ...


Physician advises diabetics to heed FDA's smart device warning

The FDA has warned diabetes patients not to use smartwatches or smart rings to measure their blood glucose levels. Now, obesity medicine expert Eleanor Yusupov, D.O., assistant professor at New York Institute of Technology ...


Focus on patient experience can improve diabetes care

Health care providers who treat diabetes need to think beyond the clinical numbers, such as solely focusing on a person's glucose goals. Taking the patient experience into account can improve the quality of care and facilitate ...

page 2 from 40